Literature DB >> 3120304

In situ characterization of the cutaneous immune response in Ethiopian cutaneous leishmaniasis.

R Nilsen1, R N Mshana.   

Abstract

Cryostat sections from 10 patients with localized cutaneous leishmaniasis (LCL) and eight patients with diffuse cutaneous leishmaniasis (DCL) from Ethiopia were studied with immunofluorescence methods for the phenotypic characterization of cells in the lesions. Higher numbers of Leu 2+ and Leu 3+ cells (P less than 0.005) were found in LCL than in DCL, while the Leu 3a + b/Leu 2a ratios were the same. No differences were found in the numbers of transferrin receptor, HLA-DR, and HLA-DQ expressing cells in the granulomas. Significantly (P less than 0.0001) lower numbers of IL-2 receptors expressing (Tac+) cells were found in DCL than LCL lesions, suggesting interference in the activation of the T cells. IL-2-containing cells were absent in DCL and were found in LCL lesions. Epidermal keratinocytes above the LCL but not the DCL lesions expressed HLA-DR (but not HLA-DQ) antigen, suggesting a lower gamma-interferon production in the DCL granulomas. The number of Langerhans' cells (Leu 6+) was higher in the epidermis of DCL (P less than 0.005) than in LCL, while a lower number of Leu 6+ cells were seen in the dermal lesions (P less than 0.001). These observations could account for some of the mechanisms responsible for the disturbed immunostimulation and immunoregulation observed in the lesions of DCL.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3120304     DOI: 10.1111/j.1365-3083.1987.tb02284.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  9 in total

1.  Effector memory CD4(+) T cells differentially express activation associated molecules depending on the duration of American cutaneous leishmaniasis lesions.

Authors:  C de Oliveira Mendes-Aguiar; R Vieira-Gonçalves; L H Guimarães; M P de Oliveira-Neto; E M Carvalho; A M Da-Cruz
Journal:  Clin Exp Immunol       Date:  2016-06-06       Impact factor: 4.330

2.  Antigen requirements for efficient priming of CD8+ T cells by Leishmania major-infected dendritic cells.

Authors:  Sylvie Bertholet; Alain Debrabant; Farhat Afrin; Elisabeth Caler; Susana Mendez; Khaled S Tabbara; Yasmine Belkaid; David L Sacks
Journal:  Infect Immun       Date:  2005-10       Impact factor: 3.441

3.  Comparison of the immune profile of nonhealing cutaneous Leishmaniasis patients with those with active lesions and those who have recovered from infection.

Authors:  S Ajdary; M H Alimohammadian; M B Eslami; K Kemp; A Kharazmi
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

4.  Increased expression of proinflammatory cytokines in chronic lesions of human cutaneous leishmaniasis.

Authors:  P C Melby; F J Andrade-Narvaez; B J Darnell; G Valencia-Pacheco; V V Tryon; A Palomo-Cetina
Journal:  Infect Immun       Date:  1994-03       Impact factor: 3.441

5.  Cell populations in the lesion of human cutaneous leishmaniasis: a light microscopical, immunohistochemical and ultrastructural study.

Authors:  P Esterre; J P Dedet; C Frenay; M Chevallier; J A Grimaud
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

6.  FasL and TRAIL signaling in the skin during cutaneous leishmaniasis - implications for tissue immunopathology and infectious control.

Authors:  Bence Rethi; Liv Eidsmo
Journal:  Front Immunol       Date:  2012-06-19       Impact factor: 7.561

7.  Local increase of arginase activity in lesions of patients with cutaneous leishmaniasis in Ethiopia.

Authors:  Tamrat Abebe; Asrat Hailu; Mihretu Woldeyes; Woinshet Mekonen; Kassahun Bilcha; Thomas Cloke; Lionel Fry; Nafisa-Katrin Seich Al Basatena; Karina Corware; Manuel Modolell; Markus Munder; Fabienne Tacchini-Cottier; Ingrid Müller; Pascale Kropf
Journal:  PLoS Negl Trop Dis       Date:  2012-06-12

8.  Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major induced Cutaneous Leishmaniasis.

Authors:  Sh Hejazi; Sg Hoseini; Sh Javanmard; Sh Zarkesh; A Khamesipour
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

9.  Interleukin-10 and Transforming Growth Factor-β in Early and Late Lesions of Patients with Leishmania major Induced Cutaneous Leishmaniasis.

Authors:  Sh Hejazi; Sg Hoseini; Sh Javanmard; Sh Zarkesh; A Khamesipour
Journal:  Iran J Parasitol       Date:  2012       Impact factor: 1.012

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.